Inverse agonists & neutral antagonists for the tsh receptor (U.S. Patent Application Number WO 2011127388 A2)
TSHR inverse agonists and neutral antagonists that are useful for treating Graves' orbitopathy, Graves' hyperthyroidism and/or thyroid cancer.